SLU-PP-332
Animal studies onlyAlmost all the research is in animals. We do not know if the same thing happens in people.
A small lab-made chemical, not a peptide. In mice it mimics some effects of exercise. No human studies.
Can a doctor prescribe this?
No. Pharmacies are not on record as being allowed to make this into a medicine.
The FDA has not approved this as a medicine.
Research chemical only. Never tested in people and not something a doctor can prescribe.
Official status: Not on the 503A bulks list. Checked 2026-08-04.
Lab suppliers we list: 8
Doses used in research
Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.
No dosing information has been published in the research indexed here.
- An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.
Animal study, rats or mice
The Journal of pharmacology and experimental therapeutics · 2026
- Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.
Animal study, rats or mice
Drug testing and analysis · 2026
- A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Animal study, rats or mice
The Journal of pharmacology and experimental therapeutics · 2024
- Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.
Animal study, rats or mice
The American journal of pathology · 2023
- A Synthetic ERRα Agonist Induces an Acute Aerobic Exercise Response and Enhances Exercise Capacity
Animal study, rats or mice
Journal not recorded · 2022
- Novel ERR pan-agonists ameliorate heart failure through boosting cardiac fatty acid metabolism and mitochondrial function
Animal study, rats or mice
Journal not recorded · 2022
- In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.
Lab dish study
Rapid communications in mass spectrometry : RCM · 2026
- Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.
Lab dish study
Circulation · 2024
- Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.
Lab dish study
ACS chemical biology · 2023
- Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study.
Frontiers in physiology · 2025
- Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling.
Review of earlier work
International journal of biological macromolecules · 2026
- [Pharmacological Activation of ERRα/β/γ as an Exercise Mimetic: Potential Therapeutic Applications].
Review of earlier work
Revista medica de Chile · 2026